TherapeuticsMD
TXMD • NASDAQ
TherapeuticsMD is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Marlan D. Walker, with a market cap of $24.3M.
CEOMarlan D. Walker
Market Cap$24.3M
Drug Manufacturers - Specialty & Generic
Healthcare
Employees1.0
Websitetherapeuticsmd.com
Next Earnings
Upcoming earnings announcement for TherapeuticsMD
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for TherapeuticsMD
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$0.06 | — | $893.0K | — |  10-K/A |
| Nov 12, 2025 | Q3 2025 | $0.00 | — | $784.0K | — | 10-Q |
| Aug 12, 2025 | Q2 2025 | $0.05 | — | $1.0M | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.06 | — | $393.0K | — | 10-Q |
| Mar 27, 2025 | Q4 2024 | $0.01 | — | $667.0K | — | 10-K/A |
| Nov 12, 2024 | Q3 2024 | -$0.05 | — | $547.0K | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.09 | — | $234.0K | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.07 | — | $313.0K | — | 10-Q |
| Mar 29, 2024 | Q4 2023 | -$0.14 | — | $502.0K | — | — |
| Nov 14, 2023 | Q3 2023 | -$0.13Est: -$0.05 | -160.0% | -$53.0KEst: $500.0K | -110.6% | — |
| Aug 14, 2023 | Q2 2023 | -$0.24Est: -$0.07 | -242.9% | $437.0KEst: $500.0K | -12.6% | — |
| May 15, 2023 | Q1 2023 | -$0.24Est: $0.06 | -500.0% | $416.0KEst: $1.7M | -75.5% | — |